IRD
Opus Genetics, Inc.
4.60$
+1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -225.7% | – | – | – | – | – | – | – | – | – | – | |
| – | +200.0% | -100.0% | – | – | – | +30.0% | +7.7% | -7.1% | +0.0% | +0.0% | +7.7% | – | |
| – | +24.1% | +38.5% | -18.2% | -3.7% | +2.4% | +14.8% | -1.9% | -8.9% | -5.1% | +89.1% | -3.9% | – | |
| – | – | -95.4% | -184.3% | – | -12.9% | -120.9% | – | – | -91.7% | -239.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | -2.7% | – | +1,072.4% | -102.2% | -71.6% | – | – | |
| – | -33.0% | -34.1% | -35.2% | -77.1% | -123.5% | – | -95.6% | +401.4% | +430.7% | +14.5% | +48.2% | – | |
| – | +243.5% | -141.0% | – | – | – | – | -181.6% | – | – | +4.1% | +94.7% | – | |
| – | – | -225.7% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.